Williston, VT, United States of America

Cordell E Gross


Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 78(Granted Patents)


Location History:

  • South Burlington, VT (US) (1998 - 2002)
  • Williston, VT (US) (1999 - 2010)

Company Filing History:


Years Active: 1998-2010

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Cordell E. Gross

Introduction

Cordell E. Gross, based in Williston, Vermont, has made significant contributions to the field of medical science through his innovative work. With a total of eight patents, Gross has focused on advancing treatments related to stroke and associated medical conditions.

Latest Patents

Among Gross's latest inventions is a method for the co-administration of a tissue plasminogen activator, an anti-CD11b antibody, and an anti-CD18 antibody in patients suffering from focal ischemic stroke. This innovative approach aims to enhance clinical outcomes by increasing cerebral blood flow and reducing infarct size without the need to remove the arterial obstruction.

Another notable patent by Gross involves methods and products related to 16-HETE analogs. This invention features agonists and antagonists of 16-HETE, presented in pharmaceutically acceptable formulations. Furthermore, this invention outlines techniques for inhibiting neutrophil adhesion and aggregation using 16-HETE agonists, which can be administered in combination with thrombolytic agents for patients experiencing thromboembolic strokes.

Career Highlights

Gross's career has been marked by his affiliation with esteemed institutions. He has notably worked with the University of Vermont and State Agricultural College, as well as Genentech, Inc., where he has collaborated on groundbreaking research and innovative practices that focus on therapeutic advancements.

Collaborations

During his career, Cordell E. Gross has collaborated with distinguished colleagues, including Martin M. Bednar and Michael Balazy. Their partnerships have fostered an environment of creativity and innovation, leading to significant contributions to medical science and patent development.

Conclusion

Cordell E. Gross continues to be a prominent figure in the domain of medical innovation. His dedication to enhancing therapeutic approaches for stroke and related conditions through patented inventions demonstrates his commitment to improving patient outcomes and advancing medical knowledge. As he forges ahead, Gross's work will undoubtedly leave a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…